拓新药业: management transactions · France · AMF SZSE:301089 FR FR · AMF Mcap 3.5Bn€
Browse the full management transaction log of 拓新药业, a listed equity based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €3.5bn. The latest transaction was disclosed on 23 February 2023 — Sale. Among the most active insiders: 蔡玉瑛. All data is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 378.3 M€
Gross profit 99.8 M€ 26% margin
Net income −69.7 M€ -18.4% margin
Balance sheet & cash
Market cap 3.54 Bn€
Total debt 3.3 M€
Free Cash Flow −70.6 M€
Last declaration on 23 February 2023
Declarations 10 total
Executives ● Sale7 SZSE
50,000 shares
SZSE:173000006306768450 · 23 Feb 2023
Executives ● Sale7 SZSE
8,600 shares
SZSE:173000006136669900 · 15 Dec 2022
Executives ● Sale7 SZSE
25,000 shares
SZSE:173000006130764580 · 13 Dec 2022
Executives ● Sale7 SZSE
51,300 shares
SZSE:173000006130764600 · 13 Dec 2022
Executives ● Sale7 SZSE
130,000 shares
SZSE:173000006118428130 · 8 Dec 2022
Executives ● Sale7 SZSE
91,000 shares
SZSE:173000006112877600 · 6 Dec 2022
Executives ● Sale7 SZSE
76,500 shares
SZSE:173000006108811200 · 5 Dec 2022
Executives ● Sale7 SZSE
99,500 shares
SZSE:173000006108811170 · 5 Dec 2022
Executives ● Sale7 SZSE
150,000 shares
SZSE:173000006091123900 · 29 Nov 2022
Executives ● Sale7 SZSE
121,000 shares
SZSE:173000006084486340 · 28 Nov 2022